The Department of Health and Human Services has agreed to purchase 66 million doses of Moderna’s omicron-specific COVID-19 vaccine booster for use this fall if authorized by the Food and Drug Administration and recommended by the Centers for Disease Control and Prevention. HHS similarly agreed to purchase at least 105 million doses of Pfizer’s omicron-specific vaccine last month. Both the Moderna and Pfizer agreements include the option to purchase up to 300 million doses from each company, which would require additional funding from Congress.
 

Related News Articles

Headline
AHA will co-host a Sept. 27 Facebook Live event with AdventHealth on the importance of getting children vaccinated and boosted against COVID-19, which will…
Headline
Insured and uninsured Americans can receive the new bivalent Pfizer or Moderna COVID-19 booster and other COVID-19 vaccines at no cost as long as the federal…
Headline
The Biden Administration will make over 170 million doses of the bivalent COVID-19 vaccine booster available to Americans for free at pharmacies, doctor’s…
Headline
The Centers for Disease Control and Prevention last week recommended Pfizer’s updated COVID-19 vaccine booster for Americans aged 12 and older and Moderna…
Headline
The Food and Drug Administration yesterday announced it has amended the emergency use authorizations for Pfizer’s and Moderna’s COVID-19 vaccines to…
Headline
Pfizer yesterday announced its application for an emergency use authorization for a COVID-19 vaccine booster that is designed to protect against the SARS-CoV-2…